Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes

OBJECTIVE: Patients with type 2 diabetes have a high risk of non-alcoholic fatty liver disease (NAFLD) and related liver fibrosis. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have demonstrated efficacy in improving NAFLD, while their effectiveness on liver fibrosis is limited in type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Yijiong, Zhen, Qin, Ding, Xiaoying, Shen, Tingting, Liu, Fang, Wang, Yufan, Zhang, Qidi, Lin, Renkun, Chen, Lili, Peng, Yongde, Fan, Nengguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399467/
https://www.ncbi.nlm.nih.gov/pubmed/36034438
http://dx.doi.org/10.3389/fendo.2022.935180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399467/
https://www.ncbi.nlm.nih.gov/pubmed/36034438
http://dx.doi.org/10.3389/fendo.2022.935180

Ejemplares similares